Maxim Topaz

Maxim Topaz

Auto-generated profile, based on publicly available information

Maxim Topaz

School of Nursing Columbia University New York New York USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2021 in Journal of Advanced Nursing
Verified
Journal Article
Open access
PDF file
CRCharlene Esteban Ronquillo
Charlene Esteban Ronquillo
LPLaura‐Maria Peltonen
Laura‐Maria Peltonen
LPLisiane Pruinelli
Lisiane Pruinelli
CCCharlene H Chu
Charlene H Chu
SBSuzanne Bakken
Suzanne Bakken
MTMaxim Topaz
Maxim Topaz
Aim: To develop a consensus paper on the central points of an international invitational think‐tank on nursing and artificial intelligence (AI).Methods: We established the Nursing and Artificial Intelligence Leadership (NAIL) Collaborative, comprising interdisciplinary experts in AI development, biomedical ethics, AI in primary care, AI legal aspects, philosophy of AI in health, nursing practice, implementation science, leaders in health informatics practice and international health informatics groups, a representative of patients and the public, and the Chair of the ITU/WHO Focus Group on Artificial Intelligence for Health. The NAIL Collaborative convened at a 3‐day invitational think tank in autumn 2019. Activities included a pre‐event survey, expert presentations and working sessions to identify priority areas for action, opportunities and recommendations to address these. In this paper, we summarize the key discussion points and notes from the aforementioned activities.Implications for nursing: Nursing's limited current engagement with discourses on AI and health posts a risk that the profession is not part of the conversations that have potentially significant impacts on nursing practice.Conclusion: There are numerous gaps and a timely need for the nursing profession to be among the leaders and drivers of conversations around AI in health systems.Impact: We outline crucial gaps where focused effort is required for nursing to take a leadership role in shaping AI use in health systems. Three priorities were identified that need to be addressed in the near future: (a) Nurses must understand the relationship between the data they collect and AI technologies they use; (b) Nurses need to be meaningfully involved in all stages of AI: from development to implementation; and (c) There is a substantial untapped and an unexplored potential for nursing to contribute to the development of AI technologies for global health and humanitarian efforts.

13 March 2017 in Health Services Research
Verified
Journal Article
Open access
PDF file
ANAmol S. Navathe
Amol S. Navathe
FZFeiran Zhong
Feiran Zhong
VLVictor J. Lei
Victor J. Lei
FCFrank Y. Chang
Frank Y. Chang
MSMargarita Sordo
Margarita Sordo
LZLi Zhou
Li Zhou
Objective: To evaluate the prevalence of seven social factors using physician notes as compared to claims and structured electronic health records (EHRs) data and the resulting association with 30‐day readmissions.Study Setting: A multihospital academic health system in southeastern Massachusetts.Study Design: An observational study of 49,319 patients with cardiovascular disease admitted from January 1, 2011, to December 31, 2013, using multivariable logistic regression to adjust for patient characteristics.Data Collection/Extraction Methods: All‐payer claims, EHR data, and physician notes extracted from a centralized clinical registry.Principal Findings: All seven social characteristics were identified at the highest rates in physician notes. For example, we identified 14,872 patient admissions with poor social support in physician notes, increasing the prevalence from 0.4 percent using ICD‐9 codes and structured EHR data to 16.0 percent. Compared to an 18.6 percent baseline readmission rate, risk‐adjusted analysis showed higher readmission risk for patients with housing instability (readmission rate 24.5 percent; p < .001), depression (20.6 percent; p < .001), drug abuse (20.2 percent; p = .01), and poor social support (20.0 percent; p = .01).Conclusions: The seven social risk factors studied are substantially more prevalent than represented in administrative data. Automated methods for analyzing physician notes may enable better identification of patients with social needs.

1 January 2019 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Open access
NDNeil Dhopeshwarkar
Neil Dhopeshwarkar
ASAziz Sheikh
Aziz Sheikh
RDRaymond Doan
Raymond Doan
MTMaxim Topaz
Maxim Topaz
DBDavid W. Bates
David W. Bates
LZLi Zhou
Li Zhou
Although drugs represent a common cause of anaphylaxis, few large studies of drug-induced anaphylaxis have been performed. To describe the epidemiology and validity of reported drug-induced anaphylaxis in the electronic health records (EHRs) of a large United States health care system. Using EHR drug allergy data from 1995 to 2013, we determined the population prevalence of anaphylaxis including anaphylaxis prevalence over time, and the most commonly implicated drugs/drug classes reported to cause anaphylaxis. Patient risk factors for drug-induced anaphylaxis were assessed using a logistic regression model. Serum tryptase and allergist visits were used to assess the validity and follow-up of EHR-reported anaphylaxis. Among 1,756,481 patients, 19,836 (1.1%) reported drug-induced anaphylaxis; penicillins (45.9 per 10,000), sulfonamide antibiotics (15.1 per 10,000), and nonsteroidal anti-inflammatory drugs (NSAIDs) (13.0 per 10,000) were most commonly implicated. Patients with white race (odds ratio [OR] 2.38, 95% CI 2.27-2.49), female sex (OR 2.20, 95% CI 2.13-2.28), systemic mastocytosis (OR 4.60, 95% CI 2.66-7.94), Sjögren's syndrome (OR 1.94, 95% CI 1.47-2.56), and asthma (OR 1.50, 95% CI 1.43-1.59) had an increased odds of drug-induced anaphylaxis. Serum tryptase was performed in 135 (<1%) anaphylaxis cases and 1,587 patients (8.0%) saw an allergist for follow-up. EHR-reported anaphylaxis occurred in approximately 1% of patients, most commonly from penicillins, sulfonamide antibiotics, and NSAIDs. Females, whites, and patients with mastocytosis, Sjögren's syndrome, and asthma had increased odds of reporting drug-induced anaphylaxis. The low observed frequency of tryptase testing and specialist evaluation emphasize the importance of educating providers on anaphylaxis management.

17 November 2015 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
MTMaxim Topaz
Maxim Topaz
DSDiane L Seger
Diane L Seger
SSSarah P Slight
Sarah P Slight
FGFoster Goss
Foster Goss
KLKenneth Lai
Kenneth Lai
LZLi Zhou
Li Zhou
Objective There have been growing concerns about the impact of drug allergy alerts on patient safety and provider alert fatigue. The authors aimed to explore the common drug allergy alerts over the last 10 years and the reasons why providers tend to override these alerts. Design: Retrospective observational cross-sectional study (2004–2013). Materials and Methods Drug allergy alert data (n = 611,192) were collected from two large academic hospitals in Boston, MA (USA). Results Overall, the authors found an increase in the rate of drug allergy alert overrides, from 83.3% in 2004 to 87.6% in 2013 (P < .001). Alarmingly, alerts for immune mediated and life threatening reactions with definite allergen and prescribed medication matches were overridden 72.8% and 74.1% of the time, respectively. However, providers were less likely to override these alerts compared to possible (cross-sensitivity) or probable (allergen group) matches (P < .001). The most common drug allergy alerts were triggered by allergies to narcotics (48%) and other analgesics (6%), antibiotics (10%), and statins (2%). Only slightly more than one-third of the reactions (34.2%) were potentially immune mediated. Finally, more than half of the overrides reasons pointed to irrelevant alerts (i.e., patient has tolerated the medication before, 50.9%) and providers were significantly more likely to override repeated alerts (89.7%) rather than first time alerts (77.4%, P < .001). Discussion and Conclusions These findings underline the urgent need for more efforts to provide more accurate and relevant drug allergy alerts to help reduce alert override rates and improve alert fatigue.

1 February 2019 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
MTMaxim Topaz
Maxim Topaz
LMLudmila Murga
Ludmila Murga
KGKatherine M. Gaddis
Katherine M. Gaddis
MMMargaret V. McDonald
Margaret V. McDonald
OBOfrit Bar-Bachar
Ofrit Bar-Bachar
KBKathryn H. Bowles
Kathryn H. Bowles

1 June 2015 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
KLKenneth H. Lai
Kenneth H. Lai
MTMaxim Topaz
Maxim Topaz
FGFoster R. Goss
Foster R. Goss
LZLi Zhou
Li Zhou